Cytovale

Cytovale is a biotechnology company focused on revolutionizing the diagnosis of sepsis through rapid and accurate testing solutions. They make money by developing and selling diagnostic devices that utilize advanced microfluidics and machine learning to analyze white blood cells, providing critical information to healthcare providers in emergency settings. Founded in 2013, Cytovale has gained attention for its innovative approach to addressing a significant medical challenge, aiming to reduce the high mortality rates associated with sepsis through early detection and intervention.

Recent Posts by Cytovale

1-5 of 5